Literature DB >> 15715871

A versatile system for the expression of nonmodified bacteriocins in Escherichia coli.

A B Ingham1, K W Sproat, M L V Tizard, R J Moore.   

Abstract

AIMS: To develop a method and plasmid vectors suitable for expression of class II bacteriocins from Escherichia coli. METHODS AND
RESULTS: The expression vector pSuV1 was constructed by inserting the PelB secretion signal coding sequence and a number of restriction endonuclease sites for cloning, into pTYB1. Codon optimized genes encoding the active mature region of each bacteriocin were constructed and inserted into pSuV1. Transfer of these constructs to a host expressing T7 RNA polymerase allowed for expression of secreted mature or fusion forms of the bacteriocins. Generation of the fusion, to the adjacent intein-chitin-binding domain gene, was achieved by removal of a small intervening BseRI fragment. The bacteriocins BacR1, divercin V41, enterocin P, pediocin PA-1 and piscicolin 126 were expressed from this system. For piscicolin 126, expression levels of 200 microg l(-1) in the mature form and 1100 microg l(-1) when cleaved from the fusion partner were achieved. All expressed bacteriocins displayed antimicrobial activity.
CONCLUSIONS: Several class II bacteriocins have been expressed in E. coli using purpose designed plasmid vectors described here. SIGNIFICANCE AND IMPACT OF THE STUDY: This method provides a common expression system capable of producing a range of different class II bacteriocins. It allows researchers to study class II bacteriocins without access to the original producer strain, the native bacteriocin gene, or highly specific heterologous producing strains. Resulting expression levels are as high or higher than those previously reported for related bacteriocins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715871     DOI: 10.1111/j.1365-2672.2004.02502.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  8 in total

1.  Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361.

Authors:  Gaoyan Wang; David C Manns; John J Churey; Randy W Worobo
Journal:  Appl Environ Microbiol       Date:  2014-06       Impact factor: 4.792

Review 2.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

4.  Controlled functional expression of the bacteriocins pediocin PA-1 and bactofencin A in Escherichia coli.

Authors:  Beatriz Mesa-Pereira; Paula M O'Connor; Mary C Rea; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

Review 5.  Heterologous Expression of Biopreservative Bacteriocins With a View to Low Cost Production.

Authors:  Beatriz Mesa-Pereira; Mary C Rea; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Front Microbiol       Date:  2018-07-26       Impact factor: 5.640

6.  Expression of bacteriocin divercin AS7 in Escherichia coli and its functional analysis.

Authors:  Agnieszka K Olejnik-Schmidt; Marcin T Schmidt; Anna Sip; Tomasz Szablewski; Włodzimierz Grajek
Journal:  Ann Microbiol       Date:  2013-11-27       Impact factor: 2.112

7.  Biotechnical paving of recombinant enterocin A as the candidate of anti-Listeria agent.

Authors:  Xiaoyuan Hu; Ruoyu Mao; Yong Zhang; Da Teng; Xiumin Wang; Di Xi; Jianzhong Huang; Jianhua Wang
Journal:  BMC Microbiol       Date:  2014-08-28       Impact factor: 3.605

Review 8.  Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli.

Authors:  Yifeng Li
Journal:  Biotechnol Appl Biochem       Date:  2009-07-06       Impact factor: 2.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.